Anita T. Shaffer

November 04, 2019

Linking a targeted drug to a chemotherapy shows promise for treating metastatic triple-negative breast cancer.

June 12, 2017

Adding Perjeta (pertuzumab) to postoperative Herceptin (trastuzumab) improved survival in certain patients with breast cancer.

June 05, 2017

Some newly diagnosed patients with prostate cancer reduced their risk of death with earlier use of Zytiga, according to two trials presented at the ASCO Annual Meeting.

June 03, 2017

A recent study proved an online program to be helpful in reducing anxiety in many newly diagnosed patients.

December 02, 2016

A recently launched clinical trial is exploring a new agent to treat patients with advanced, recurrent, platinum-resistant ovarian cancer.

November 15, 2016

According to results from a recent study, Keytruda had longer overall survival (OS) when compared to chemotherapy for patients with bladder cancer.

October 25, 2016

In some cases, genomic blood analysis may be effective enough to replace cancer biopsies.

August 18, 2016

The best use of liquid biopsies in late-stage non–small cell lung cancer (NSCLC) will be to augment tissue biopsies at initial diagnosis and to evaluate patients for second- and third-line therapies.

June 27, 2016

Scientists are enthusiastic about new technology that will be able to edit human genes.

June 07, 2016

In a recent study, patients with lung cancer who used an online app to track their symptoms saw a higher overall survival rate than those who didn't.

June 05, 2016

Though more research still needs to be done, potential for liquid biopsies was shown in a study involving 15,000 patients who represented a multitude of cancer types.

June 04, 2016

Recent findings may make way for a less expensive treatment option for patients with metastatic breast cancer.

June 02, 2016

Checkpoint blockade immunotherapies like Keytruda are increasing the OS rates for patients with advanced melanoma.

May 26, 2016

In the fast-moving world of melanoma treatment, new therapeutic options for patients with metastatic disease are emerging faster than oncology researchers can establish guidelines for their optimal clinical use. That is raising questions about which should be the firstline choice in metastatic melanoma — targeted drugs or immunotherapy — and how these drugs should be sequenced.

April 29, 2016

In an interview with CURE, John L. Marshall emphasized that treating GI cancers is a "team sport."

March 23, 2016

March 09, 2016

For Shvon Lowe, an invitation from a friend to attend the Sisters Network 5K turned into being something much bigger in her life.

February 25, 2016

December 13, 2015

Gene therapy has the potential to deliver long-lasting remissions for patients with advanced B-cell malignancies who already have undergone an allogeneic hematopoietic stem cell transplant.

December 11, 2015

Less than two years after Imbruvica gained approval for patients with CLL, a second-generation agent has demonstrated a 95 percent response rate.

December 09, 2015

The addition of the PD-1 inhibitor Keytruda (pembrolizumab) to an established multiple myeloma regimen elicited responses in 76 percent of 17 patients with relapsed/refractory disease.

August 17, 2015

Adjuvant whole brain radiation therapy (WBRT) dramatically increases the incidence of cognitive decline without survival benefit in patients with small brain metastases from other tumor types.

June 05, 2015

When cancers that originate elsewhere cause small metastases in the brain, initial treatment should not routinely be followed by whole brain radiation therapy, because that strategy dramatically increases the chances of cognitive decline without improving survival outcomes.

June 04, 2015

An ambitious clinical trial set to start in July will match patients to treatments based on molecular abnormalities, rather than cancer types, testing 20 targeted drugs at once.

June 02, 2015

When melanoma metastacizes, the lymph node to which it has spread is typically removed. But what if micrometastases are found in other nearby lymph nodes? Should patients undergo a complete dissection, or removal, of all the nodes in the area?

May 08, 2015

A two-pronged strategy combining the PARP inhibitor Lynparza and the PI3K inhibitor BKM120 proved to be a safe and clinically beneficial regimen for women with TNBC and for patients with high-grade serous ovarian cancer.

March 10, 2015

CURE editor-in-chief and breast oncologist, Debu Tripathy, reviews the top breast cancer research highlights from 2014.

March 03, 2015

Looking at prior treatment and efficacy data, researchers finds significant benefit with radiotherapy when given to older patients with hormone-negative invasive breast cancer who had undergone breast-conserving surgery.

March 03, 2015

A detailed tumor profile of molecular and protein alterations in a rare breast cancer subtype called metaplastic breast cancer, was one of the top studies presented at the Miami Breast Cancer Conference this year.

January 29, 2015

The Food and Drug Administration is evaluating proposals for new indications for at least 17 oncology medicines, according to Friends of Cancer Research, an advocacy group that aims to get patients cutting-edge treatments as safely and quickly as possible.